SPHERE Per-AF Post-Approval Study
NCT: NCT06858306 · ACTIVE_NOT_RECRUITING
NCT IDNCT06858306
StatusACTIVE_NOT_RECRUITING
Start Date2025-09-25
Completion2030-10
Brief Summary
SPHERE Per-AF Post-Approval Study is a prospective, multi-center, non-randomized, observational trial. Subjects will be treated with the Sphere-9™ Catheter and Affera™ Ablation System and followed through 36 months.
Frequently Asked Questions
What is SPHERE Per-AF Post-Approval Study?
SPHERE Per-AF Post-Approval Study is a clinical trial registered under NCT06858306. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06858306?
The current status of NCT06858306 (SPHERE Per-AF Post-Approval Study) is: ACTIVE_NOT_RECRUITING.
When did SPHERE Per-AF Post-Approval Study start?
SPHERE Per-AF Post-Approval Study started on 2025-09-25.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.